Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents

Glioblastoma (GBM) patients have an estimated survival of ~15 months with treatment, and the standard of care only modestly enhances patient survival. Identifying biomarkers representing vulnerabilities may allow for the selection of efficacious chemotherapy options to address personalized variation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wenjie, Rodriguez-Silva, Monica, Acanda de la Rocha, Arlet M., Wolf, Aizik L., Lai, Yanhao, Liu, Yuan, Reinhold, William C., Pommier, Yves, Chambers, Jeremy W., Tse-Dinh, Yuk-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827102/
https://www.ncbi.nlm.nih.gov/pubmed/31547492
http://dx.doi.org/10.3390/cancers11101416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827102/
https://www.ncbi.nlm.nih.gov/pubmed/31547492
http://dx.doi.org/10.3390/cancers11101416

Ejemplares similares